Particle Engineering by Dense Gas Technologies Applied to Pharmaceuticals
Access Status
Authors
Date
2012Type
Metadata
Show full item recordCitation
Source Title
ISBN
School
Collection
Abstract
Dense phase carbon dioxide is used in pharmaceutical processingsince it is nontoxic, nonflammable, inexpensive, and easily accessible. For decades it has been utilized in food and chemical processing due to its ability to provide a high degree of purification, and to produce submicron particles with uniform particle size distribution. In recent years, DPCD technology has been explored and used in pharmaceutical processing to obtain ultra-high-purity active pharmaceutical ingredients and, more significantly, to modify their physical characteristics regarding particle size distribution, crystalline structure, and surface topography crucial for the drugs stability, bioavailability, ease of delivery, and clinical performance. The aim of this chapter is to describe the application of dense phase CO 2 as a solvent or antisolvent to pharmaceutical processes, presenting the experimental equipment, the main results obtained from the application of the technology, and the advantages of using pressurized CO 2 . © 2012 Blackwell Publishing Professional.
Related items
Showing items related by title, author, creator and subject.
-
Carr, A.; Mammucari, R.; Foster, Neil (2011)Recently, subcritical water (SBCW: water that has been heated to a temperature between 100 °C and 200 °C at pressures of up to 70 bar) has been used to dissolve several hydrophobic pharmaceutical compounds (Carr et al., ...
-
Chen, X.; Shang, Y.; Li, Y.; Wang, J.; Maimouna, A.; Li, Y.; Zou, D.; Foster, Neil; Yun, J.; Pu, Y. (2015)Drugs with poor solubility in water, which indicates poor oral bioavailability, account for a considerable portion of new pharmaceutical candidates. Nanonization is a technique that overcomes this problem. However, current ...
-
Clifford, Rhonda (2004)People with diabetes mellitus are more likely to die from cardiovascular causes than those without diabetes, and modifiable risk factors, such as hyperglycaemia, dyslipidaemia and hypertension can be targeted in intervention ...